Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Standex International Corporation filings document the reporting obligations of a diversified industrial manufacturer with operations across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions. Form 8-K filings furnish quarterly results, segment performance commentary, order trends, portfolio actions, leverage updates, and exhibits tied to earnings releases.
The company’s proxy and governance filings cover director elections, advisory executive compensation votes, auditor ratification, board matters, and executive compensation disclosures. Other current reports record officer transitions and related management changes, providing formal disclosure on governance, leadership structure, financial reporting, and capital-allocation matters.
SXI issuer notice: Thomas Chorman reported a proposed sale of 50 Common shares via Fidelity Brokerage Services LLC under a Form 144 notice dated 05/01/2026. The filing also lists multiple prior dispositions in the past three months, including 513 shares sold on 02/27/2026.
Standex International Corp: Vanguard Capital Management reported beneficial ownership of 634,076 shares of Common Stock, representing 5.23% of the class as of 03/31/2026, on a Schedule 13G filing.
The filing states Vanguard Capital Management has sole dispositive power over 634,076 shares and sole voting power for 90,450 shares. The report describes holdings managed across Vanguard-affiliated entities and was signed by the Head of Global Fund Administration.
Vanguard Portfolio Management reports beneficial ownership of 751,868 shares of Standex International Corp common stock, representing 6.20% of the class. The filing shows sole voting power for 9,376 shares and sole dispositive power over 751,868 shares. The report is signed on 04/29/2026.
Standex International Corp executive Max Arets reported a routine tax-related share disposition. On April 8, 2026, 132 shares of common stock were forfeited at $272.83 per share to cover tax liability tied to vesting of previously issued restricted stock. After this withholding, Arets directly holds about 1,319.632 shares of Standex common stock.
Standex International chief legal officer Alan J. Glass reported a routine tax-withholding transaction related to vested restricted stock. On the event date, 204 common shares were forfeited at an implied price of $257.70 per share to cover tax liabilities. After this non-market disposition, he directly holds 22,722.945 common shares.
Standex International Vice President, CFO and Treasurer Ademir Sarcevic reported a tax-related share disposition. On April 1, 2026, 1,713 shares of common stock were forfeited at $260.09 per share to cover taxes on vesting of previously issued restricted stock. After this withholding, he directly holds 7,628 shares of Standex common stock.
Standex International director Thomas E. Chorman reported an open-market sale of 50 shares of Common Stock at $257.94 per share on April 1, 2026. The transaction was executed pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025.
After this sale, Chorman directly holds 12,566 shares of Standex International common stock, indicating the transaction represents a small portion of his reported holdings and appears to be a routine, pre-planned sale.
Fidelity Brokerage Services LLC submitted a Form 144-style notice reporting transactions in Common stock. The filing lists a 50-share restricted stock vesting event dated 10/26/2024 and three reported sales by Thomas Chorman on 02/04/2026 (50 shares), 02/27/2026 (513 shares), and 03/02/2026 (50 shares).
Standex International Corp — Amendment No. 16 to a Schedule 13G/A states that The Vanguard Group reports 0 shares beneficially owned, equal to 0% of common stock. The filing attributes this to an internal realignment on January 12, 2026 that disaggregated certain Vanguard subsidiaries, which now report separately. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Standex International director Thomas E. Chorman reported an open-market sale of 50 shares of Standex International common stock at $259 per share on March 2, 2026. The sale was made under an existing Rule 10b5-1 trading plan dated November 6, 2025, and he now holds 12,616 shares directly.